Suchergebnisse - "Buti, Maria"

PubPharm (18)

1

Resistance-associated substitutions after sofosbuvir/velpatasvir/voxilaprevir triple therapy failure

enthalten in: Journal of viral hepatitis | 2021

von Garcia-Cehic, D. | Rando, A. | Rodriguez-Frias, F. | +12

2

Glecaprevir/pibrentasvir for 8 weeks in treatment-naïve patients with chronic HCV genotypes 1-6 and compensated cirrhosis : The EXPEDITION-8 trial

enthalten in: Journal of hepatology | 2020

von Brown, R. | Buti, M. | Rodrigues, L. | +19

CommentIn: J Hepatol. 2020 Mar;72(3):389-390. - PMID 31703944

3

Effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in patients with chronic hepatitis C previously treated with DAAs

enthalten in: Journal of hepatology | 2019

von Llaneras, J. | Riveiro-Barciela, M. | Lens, S. | +30

4

Glecaprevir/Pibrentasvir in patients with hepatitis C virus genotype 1 or 4 and past direct-acting antiviral treatment failure

enthalten in: Hepatology (Baltimore, Md.) | 2018

von Poordad, F. | Pol, S. | Asatryan, A. | +17

5

New hepatitis C virus genotype 1 subtype naturally harbouring resistance-associated mutations to NS5A inhibitors

enthalten in: The Journal of general virology | 2018

von Ordeig, L. | Garcia-Cehic, D. | Gregori, J. | +11

6

Short article : Faldaprevir, deleobuvir and ribavirin in IL28B non-CC patients with HCV genotype-1a infection included in the SOUND-C3 phase 2b study

enthalten in: European journal of gastroenterology & hepatology | 2016

von Zeuzem, S. | Mantry, P. | Soriano, V. | +11

7

Ribavirin concentration determines treatment success of first-generation DAA-based chronic HCV therapy

enthalten in: Antiviral therapy | 2016

von de Kanter, C. | Buti, M. | DeMasi, R. | +6

8

Management of direct-acting antiviral agent failures

enthalten in: Journal of hepatology | 2015

von Buti, M. | Riveiro-Barciela, M. | Esteban, R.

9

Lead-in period and week 8 as predictive tools for response to boceprevir therapy : a retrospective study of Spanish real clinical practice

enthalten in: Gastroenterologia y hepatologia | 2015

von Crespo, J. | Berenguer, M. | Pérez, F. | +7

10

Role of ITPA and SLC28A2 genes in the prediction of anaemia associated with protease inhibitor plus ribavirin and peginterferon in hepatitis C treatment

enthalten in: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology | 2015

von Ampuero, J. | Del Campo, J. | Rojas, L. | +10